Clinical Trial

Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to evaluate a new noninvasive brain stimulation intervention for fibromyalgia and to determine its effectiveness in reducing pain. Participants will receive four treatments over the course of one month and will complete surveys at multiple time points throughout the 16-week study.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2025-11-07; most recent amendment 2026-07-10.
Status change: Not Yet Recruiting → Recruiting 2025-11-11
Trial Details
NCT Number NCT07226648
Lead Sponsor SPIRE Therapeutics Inc.
Collaborators: University of Utah Data Coordinating Center
Conditions Fibromyalgia
Enrollment 180 participants
Start Date 2025-12-11
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-13